Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viraemia”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Not applicableStudy completedNCT01782209
What this trial is testing

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

Who this might be right for
BK Virus (BKV) Viremia
University of Alabama at Birmingham 335
Large-scale testing (Phase 3)Ended earlyNCT02247687
What this trial is testing

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

Who this might be right for
HIV-1 InfectionTreatment Resistant DisordersViremia
ANRS, Emerging Infectious Diseases 4
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT02784756
What this trial is testing

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 134
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Not applicableStudy completedNCT04189835
What this trial is testing

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Who this might be right for
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more
University of Aarhus 509
Not applicableWithdrawnNCT03033017
What this trial is testing

Predictors of Time to Viremia With an Analytic Treatment Interruption

Who this might be right for
HIV
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01295515
What this trial is testing

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Early research (Phase 1)Study completedNCT02652546
What this trial is testing

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

Who this might be right for
HIV, Inflammation
National Institute of Allergy and Infectious Diseases (NIAID) 38
Post-approval studies (Phase 4)Study completedNCT00947141
What this trial is testing

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Who this might be right for
Viraemia
University College, London 165
Large-scale testing (Phase 3)Study completedNCT04649879
What this trial is testing

Convalescent Plasma for Treatment of COVID-19

Who this might be right for
Covid19
Joakim Dillner 59
Large-scale testing (Phase 3)WithdrawnNCT01605084
What this trial is testing

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Who this might be right for
HIV
Bristol-Myers Squibb
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Not applicableNot Yet RecruitingNCT07015164
What this trial is testing

Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral Therapy

Who this might be right for
HIV
Assistance Publique - Hôpitaux de Paris 80
Not applicableLooking for participantsNCT06823596
What this trial is testing

The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY

Who this might be right for
Hiv
University of Toronto 26
Not applicableStudy completedNCT01649609
What this trial is testing

Using mTOR Inhibitors in the Prevention of BK Nephropathy

Who this might be right for
BK ViremiaBK Nephropathy
Columbia University 40
Not applicableEnrolling By InvitationNCT06604663
What this trial is testing

Data Science and Qualitative Research for Decision Support in the HIV Care Cascade

Who this might be right for
Human Immunodeficiency VirusTreatment AdherenceTreatment Compliance+4 more
Brown University 80,000
Post-approval studies (Phase 4)Study completedNCT03216967
What this trial is testing

Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

Who this might be right for
BK Virus Nephropathy After Kidney Transplantation
University Hospital, Strasbourg, France 130
Load More Results